Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_assertion type Assertion NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_head.
- NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_assertion description "[The expression of the oxytocin (OT) receptor (OTR) in breast cancer was studied using newly established anti-OTR monoclonal antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_provenance.
- NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_assertion evidence source_evidence_literature NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_provenance.
- NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_assertion SIO_000772 8593829 NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_provenance.
- NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_assertion wasDerivedFrom befree-20140225 NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_provenance.
- NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_assertion wasGeneratedBy ECO_0000203 NP410379.RApfXQUimXEqvMVtvM2KIB8uM3OOJbDwN_o_zknL9hFwY130_provenance.